| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,559,000 | 6,639,000 | 6,481,000 | 7,443,000 | | Cost of Revenue | 109,000 | 105,000 | 85,000 | 454,000 | | | Gross Profit | 6,450,000 | 6,534,000 | 6,396,000 | 6,989,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,920,000 | 4,090,000 | 3,579,000 | 4,880,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,178,000 | 1,584,000 | 1,803,000 | 1,358,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,352,000 | 860,000 | 1,014,000 | 751,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,352,000 | 860,000 | 1,014,000 | 751,000 | | Interest Expense | 434,000 | 442,000 | 470,000 | 483,000 | | Income Before Tax | 918,000 | 418,000 | 544,000 | 268,000 | | Income Tax Expense | 276,000 | 76,000 | 101,000 | (38,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 642,000 | 342,000 | 443,000 | 306,000 | | | Non-recurring Events | | Discontinued Operations | (2,000) | (5,000) | (6,000) | (66,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 640,000 | 337,000 | 437,000 | 240,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $640,000 | $337,000 | $437,000 | $240,000 |
|
0.17% Nasdaq 
0.53 (1.40%) 
Income Statement
